OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 12.03.2026, 08:26

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Abstract PR-04: A practical framework for operationalizing responsible and equitable AI in healthcare: Tackling bias, inequity, and implementation challenges

2025·1 Zitationen·Clinical Cancer Research
Volltext beim Verlag öffnen

1

Zitationen

19

Autoren

2025

Jahr

Abstract

Abstract Background: Artificial intelligence (AI) is promising to rapidly transform healthcare by enhancing clinical workflows and improving patient outcomes. However, the integration of AI solutions also carries significant risk of harm due to discriminatory performance and inequitable outcomes across diverse patient populations. Existing frameworks aimed at promoting responsible AI development, such as SPIRIT-AI, CONSORT-AI, and TRIPOD+AI, provide guidelines for clinical trial design but lack concrete recommendations to identify and mitigate bias during clinical integration. Frameworks emphasizing ethical principles like equity, transparency, and accountability, including HEAAL, JustEFAB, and the Normative Framework, similarly fall short of offering detailed operational guidance for real-world AI deployment. Recognizing these gaps, we developed a novel Framework for Responsible AI Deployment in healthcare settings, incorporating structured, actionable steps to identify, mitigate, and monitor biases throughout the AI lifecycle. Methodology: Our framework (https://github.com/pmcdi/responsible-ai) was developed through a multidisciplinary collaborative approach whereby stakeholders with expertise in biostatistics, machine learning, ethics, clinical care, institutional governance, diversity and inclusion, and patient advocates, synthesized insights from existing frameworks and engaged in iterative and structured feedback sessions to ensure practical applicability and robustness. Results: This framework is organized into four distinct stages: (1) Problem Identification and Study Design, emphasizing equity-focused clinical question formulation and ethical compliance; (2) Model Training and Development, addressing biases in retrospective data and ensuring transparent performance evaluations; (3) Silent Deployment and Clinical Evaluation, prospectively validating model fairness and clinical applicability without direct patient impact; and (4) Clinical Deployment and Lifecycle Monitoring, providing continuous oversight of AI systems integrated into clinical workflows, emphasizing patient and clinician education, compliance monitoring, and adaptive maintenance. The framework is accompanied by a supplemental appendix which contextualizes each stage with concrete detail such as recommended methods, pain points to consider, and academic references for exploration. Conclusions: Our framework addresses critical shortcomings in current practices to facilitate ethical and equitable AI deployment in healthcare. We are actively working with researchers at the Princess Margaret Cancer Centre to evaluate its utility across a breadth of clinical AI solutions at all stages of development. This framework can help institutions meet their ethical obligations; ensure AI-driven innovations align with foundational healthcare principles of fairness, safety, and quality; safeguard against harm; and ultimately improve trust in AI-enhanced clinical care. Citation Format: Benjamin Grant, Mattea Welch, Christopher Deutschman, Clare McElcheran, Adam Badzynski, Jennifer A.H. Bell, Andrew Hope, Robert C. Grant, Tran Truong, Kelly Lane, Patti Leake, Divya Sharma, Ian Stedman, Mike Lovas, Jeremy Petch, Muammar Kabir, Alejandro Berlin, James A. Anderson, Benjamin Haibe-Kains. A practical framework for operationalizing responsible and equitable AI in healthcare: Tackling bias, inequity, and implementation challenges [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning; 2025 Jul 10-12; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(13_Suppl):Abstract nr PR-04.

Ähnliche Arbeiten